The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Helix Biopharma Corp

TSX: HBP
Delayed quote

$1.85

Today's change-0.11 -5.61%
Updated February 10 12:22 PM EST. Delayed by at least 15 minutes.
 

Helix Biopharma Corp

TSX: HBP
Delayed quote

$1.85

Today's change-0.11 -5.61%
Updated February 10 12:22 PM EST. Delayed by at least 15 minutes.

Helix Biopharma Corp crosses below 20-day moving average

Helix Biopharma Corp closed sharply lower Wednesday, dropping $0.11 or 5.61% to $1.85 and crossing below its 20-day moving average. Over the last five days, shares have lost 3.65% and are down 7.50% for the last year to date. This security has outperformed the S&P TSX by 45.22% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated February 10 12:22 PM EST. Delayed by at least 15 minutes.

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedOct 31, 201510/31/2015Jul 31, 201507/31/2015Apr 30, 201504/30/2015Jan 31, 201501/31/2015
Revenue----00
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3223
Selling / general / administrative1111
Research & development1111
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-3-2-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-3-2-2-3
Income after tax-3-2-2-3
Income tax, total--000
Net income-3-2-2-3
Total adjustments to net income--------
Net income before extra. items-3-2-2-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-2-2-3
Inc. avail. to common incl. extra. items-3-2-2-3
Diluted net income-3-2-2-3
Dilution adjustment--------
Diluted weighted average shares85857876
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.03-0.02-0.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.03-0.02-0.04